Q2 2022 EPS Estimates for Waters Co. (NYSE:WAT) Lowered by Analyst

Waters Co. (NYSE:WATGet Rating) – Stock analysts at SVB Leerink cut their Q2 2022 earnings estimates for shares of Waters in a research note issued to investors on Friday, May 20th. SVB Leerink analyst P. Souda now expects that the medical instruments supplier will earn $2.63 per share for the quarter, down from their prior forecast of $2.64. SVB Leerink currently has a “Market Perform” rating and a $350.00 target price on the stock. SVB Leerink also issued estimates for Waters’ Q3 2022 earnings at $2.69 EPS, Q3 2023 earnings at $2.99 EPS and Q4 2023 earnings at $3.92 EPS.

Several other research firms have also weighed in on WAT. Wells Fargo & Company raised Waters from an “underweight” rating to an “equal weight” rating and lowered their target price for the company from $320.00 to $315.00 in a report on Monday, April 25th. Barclays assumed coverage on Waters in a research note on Tuesday, May 17th. They set an “overweight” rating and a $375.00 price objective on the stock. StockNews.com assumed coverage on Waters in a research note on Thursday, March 31st. They set a “buy” rating on the stock. Cowen increased their price objective on Waters to $358.00 in a research note on Friday. Finally, Bank of America raised Waters from an “underperform” rating to a “neutral” rating and raised their price target for the stock from $320.00 to $330.00 in a research note on Tuesday, May 17th. Five investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $367.33.

NYSE:WAT opened at $318.95 on Monday. The stock has a fifty day moving average price of $315.44 and a two-hundred day moving average price of $328.52. The stock has a market capitalization of $19.21 billion, a price-to-earnings ratio of 27.90, a PEG ratio of 3.13 and a beta of 0.85. The company has a debt-to-equity ratio of 3.85, a quick ratio of 1.75 and a current ratio of 2.30. Waters has a 1 year low of $288.32 and a 1 year high of $428.22.

Waters (NYSE:WATGet Rating) last released its quarterly earnings data on Tuesday, May 3rd. The medical instruments supplier reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.32 by $0.48. The firm had revenue of $690.60 million during the quarter, compared to analysts’ expectations of $634.08 million. Waters had a return on equity of 221.08% and a net margin of 24.57%. Waters’s revenue was up 13.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.29 earnings per share.

Several institutional investors have recently bought and sold shares of WAT. Ellevest Inc. increased its holdings in shares of Waters by 144.4% in the 1st quarter. Ellevest Inc. now owns 88 shares of the medical instruments supplier’s stock worth $27,000 after acquiring an additional 52 shares during the period. Retirement Planning Co of New England Inc. acquired a new position in shares of Waters in the 4th quarter worth approximately $48,000. Kenfarb & CO. acquired a new position in shares of Waters in the 4th quarter worth approximately $48,000. Migdal Insurance & Financial Holdings Ltd. acquired a new position in shares of Waters in the 3rd quarter worth approximately $56,000. Finally, Tyler Stone Wealth Management acquired a new position in shares of Waters in the fourth quarter worth about $56,000. Institutional investors own 90.65% of the company’s stock.

Waters Company Profile (Get Rating)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Further Reading

Earnings History and Estimates for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.